A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Name: A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
Published: 2012
License: Public Domain

AVEO Pharmaceuticals, Inc. · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

monoclonal-antibody

solid tumors, av203, erbb3, monoclonal antibody, her3, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Related documents